Activist Investor 13D, 13G Filings


This page shows a list of all the recent 13D/G filings made by Drexler Ryan Charles. Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

DateForm Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2017‑11‑09 SC 13D/A MSLP / MusclePharm Corp. 10,876,766 18,417,740 69.33 59.8 28.05
2017‑09‑08 SC 13D/A MSLP / MusclePharm Corp. 10,842,943 10,876,766 0.31 46.7 -0.21
2017‑05‑04 SC 13D/A MSLP / MusclePharm Corp. 10,156,020 10,842,943 6.76 46.8 3.54
2016‑11‑15 SC 13D/A MSLP / MusclePharm Corp. 2,608,696 10,156,020 289.31 45.2 137.89
2015‑12‑18 SC 13D MSLP / MusclePharm Corp. 2,608,696 19.0